Validation of human kallikrein 6 in the cerebrospinal fluid of patients with progressive and non-progressive alzheimer’s disease: correlation with other biomarkers
We conclude that these correlations further support our previous findings and suggest that hK6 may be an additional biomarker for AD and may play some role in the pathogenesis of AD.
Authors
- Ioannis Prassas (ORCID: https://orcid.org/0000-0002-7907-4576)
- Adelina Orellana (ORCID: https://orcid.org/0000-0002-0204-1944)
- Miyo K. Chatanaka (ORCID: https://orcid.org/0000-0002-5864-8315)
- Eleftherios P. Diamandis (ORCID: https://orcid.org/0000-0002-1589-820X)
- Antoninus Soosaipillai
- M. Boada
- A. Cano
- Xavier Morató
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Instituto de Salud Carlos III (ES)
- Universitat Internacional de Catalunya (ES)
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
Publication Details
- Journal
- Clinical Proteomics
- Published
- 2026-03-15
- DOI
- https://doi.org/10.1186/s12014-025-09577-x
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 0.00